Your browser doesn't support javascript.
loading
Case Report: A case of hepatocellular carcinoma with aberrant right hepatic artery treated with transarterial chemoembolization and infusion chemotherapy separately to bilobar lesion combining with systemic therapies and sequential hepatectomy.
Wei, Yong-Guang; Su, Hao; Lv, Zi-Li; Liao, Xi-Wen; Zeng, Zhi-Ming; Jia, Yu-Xuan; Huang, Hua-Sheng; Shen, Xiao-Qiang; Zhu, Guang-Zhi; Han, Chuang-Ye; Ye, Xin-Ping; Peng, Tao.
Afiliação
  • Wei YG; Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, China.
  • Su H; Guangxi Key Laboratory of Enhanced Recovery after Surgery for Gastrointestinal Cancer, Guangxi Medical University, Nanning, China.
  • Lv ZL; Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, China.
  • Liao XW; Guangxi Key Laboratory of Enhanced Recovery after Surgery for Gastrointestinal Cancer, Guangxi Medical University, Nanning, China.
  • Zeng ZM; Department of Pathology, The First Affiliated Hospital of Guangxi Medical University, Nanning, China.
  • Jia YX; Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, China.
  • Huang HS; Guangxi Key Laboratory of Enhanced Recovery after Surgery for Gastrointestinal Cancer, Guangxi Medical University, Nanning, China.
  • Shen XQ; Department of Oncology, The First Affiliated Hospital of Guangxi Medical University, Nanning, China.
  • Zhu GZ; Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, China.
  • Han CY; Guangxi Key Laboratory of Enhanced Recovery after Surgery for Gastrointestinal Cancer, Guangxi Medical University, Nanning, China.
  • Ye XP; Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, China.
  • Peng T; Guangxi Key Laboratory of Enhanced Recovery after Surgery for Gastrointestinal Cancer, Guangxi Medical University, Nanning, China.
Front Oncol ; 13: 1165538, 2023.
Article em En | MEDLINE | ID: mdl-37469401

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2023 Tipo de documento: Article